Elizabeth Aradine1, Yan Hou1, Carolyn A Cronin1, Seemant Chaturvedi2. 1. Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA. 2. Stroke Division and Department of Neurology, University of Maryland School of Medicine, 110 S. Paca St., Baltimore, MD, 21201, USA. Schaturvedi@som.umaryland.edu.
Abstract
PURPOSE OF REVIEW: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. RECENT FINDINGS: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin-kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.
PURPOSE OF REVIEW: Elevated cholesterol is an established risk factor for ischemic stroke. The value of statins for stroke prevention has been clear for more than a decade. RECENT FINDINGS: However, the use of new medication combinations such as ezetimibe or proprotein convertase subtilisin-kexin type 9 inhibitors plus statins is increasing and the value for reducing stroke has been shown for these combination therapies. Recent data also support the strategy of lowering triglycerides for stroke prevention. A modern approach to dyslipidemia treatment and its relation to stroke prevention is summarized in this paper.